BTG (BTG)

Sector: Biotechnology     Index: FTSE 250
-0.19%
-1.50p
804.00p
16:45 19/12/14

   Trade now with Barclays Stockbrokers   Trade now with Barclays Sponsored by Barclays Stockbrokers

804.00p
16:45 19/12/14
DAILY VARIATION
-0.19%
-1.50p
VOLUME
954,559
REAL TIME BATS
804.00p
16:45 19/12/14
-0.19%
-1.50p
DATA
52 Week High
811.00p
52 Week Low
496.50p
Shares Issued
381.70m
Market Cap
£3,013.52m
RiskGrade
n/a
Beta
1.08
MENU

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 9.4% 14.9%
ROCE 27.4%
Latest F'cast
P/E 55.4 48.7
PEG 0.0 5.5
Pr/Revenue 10.6 8.7
Pr/Book 5.8
Latest F'cast
Revenue 24.3% 2.3%
PBT 38.2% n/a
EPS 0.0% -12.7%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2010-03-31 98.50 9.10 6.90p 25.8 0.0 527% n/a 0.0%
2011-03-31 111.40 -10.80 1.00p 227.6 -2.7 -86% n/a 0.0%
2012-03-31 197.00 23.00 11.40p 29.3 0.0 1,040% n/a 0.0%
2013-03-31 233.70 24.10 14.50p 24.6 0.9 27% n/a 0.0%
2014-03-31 290.50 33.30 14.50p 37.4 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2015-03-31 351.54 52.27 15.83p 48.7 5.3 9% 0.00p 0.0%
2016-03-31 419.34 90.39 21.96p 37.0 1.0 39% 0.00p 0.0%

Regulatory News

slide to see more

Latest Sharecast News

slide to see more